Global Cell-Free DNA (cfDNA) Markets Opportunity Report 2016-2021: Focus on Consumables, Systems/Hardware, Services

Dublin, March 06, 2017 -- Research and Markets has announced the addition of the "Cell-Free DNA (cfDNA) Markets: Consumables, Systems/Hardware, Services" report to their offering.

Cell-Free DNA (cfDNA) Markets: Consumables, Systems/Hardware, Services examines the opportunity for cell-free DNA analysis instruments, consumables, kits, and related software.

Current sales analysis and projections to 2021 are provided, as well as measurements of market growth; sales by product type; sales revenues of major competitors in the market; and geographic performance in North America, Europe, Asia-Pacific, and the rest of the world. Intellectual Property Litigation in the cfDNA analysis market is discussed, as well as collaborations.

Illumina and Thermo Fisher Scientific are among the manufacturers discussed in the report's competitor analysis. Market challenges and responses to these challenges are also presented

Key Topics Covered:

Chapter 1: Executive Summary
NIPT, Oncology Leading Market Forward
Sensitivity Benefits of dPCR, qPCR, NGS
Challenges, Biological and Technologies Limitations
Scope and Methodology

Chapter 2: Introduction
NIPT Companies, Others Shifting Strategies to Cancer
Expanding Clinical Adoption Sustains High Growth
Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas
Mergers, Acquisitions, Equity Investments Increasing
China Becoming Major Player in Market
Personalized, Proactive Medicine Gaining Momentum
Expected Sequencer Platforms Stalled or Cancelled
Significant Efforts in Automation, Miniaturization
Regulatory Situation Unclear But Evolving Somewhat

Chapter 3: cfDNA Analysis Products
cfDNA Reagents, Consumables, and Kits
cfDNA Systems and Software
cfDNA NIPT Products and Services
cfDNA in Oncology, Transplantation and Other Diseases
cfDNA Other Products
Recent Product/ Service Introductions
2016
2015
2014
2013
2012

Chapter 4: Market Analysis
Revenues Forecast
Market Size and Forecast
cfDNA Clinical Diagnostics Market
cfDNA Market by Region
Revenues by Product Type
Illumina Sequencing Revenues as Indicator

Chapter 5: cfDNA Instruments and Consumables Competitive Analysis
Introduction
cfDNA Instruments and Consumables Market Shares

Chapter 6: Intellectual Property and Litigation
Sequenom, Several NIPT Companies Fighting
Ariosa Diagnostics (Roche) Files Suit Against Sequenom
Natera Sues Sequenom; Sequenom Sues Natera
Verinata Health and Stanford File Against Sequenom
Verinata Health Against Ariosa and LabCorp
Illumina Sues Ariosa Diagnostics for NIPT Test
Illumina Sues Premaitha Health for NIPT Test
Illumina Sues Premaitha and Ariosa Partners
Sequenom and Illumina Settle and Pool Patents
Sequenom Petitions Supreme Court
Illumina Sues Qiagen for GeneReader System
Illumina's Conflicts with Oxford Nanopore
Enzo Biochem Brings Suit Against Numerous Companies
Cell-Free DNA Markets
RainDance Technologies Sues 10X Genomics
10X Genomics' Dispute with Bio-Rad
Sequenom Shareholder Sues Over Price Capping
Helicos' Patent Infringement Suit Against PacBio, Life Technologies, and Illumina
Illumina's Two Lawsuits Against Complete Genomics for Infringement
Life Technologies and Illumina Dispute Over Amplification on Solid Surfaces
Enzo Biochem Disputes Sequencing Patents
LabCorp's Esoterix Sues Life Technologies
Genetic Technologies Sues Several Firms for Infringement of Haplotype Determination Technique

Chapter 7: cfDNA Analysis Market Deals
The Significant Collaborations

Chapter 8: cfDNA Instruments and Consumables Market Corporate Profiles
Agilent Technologies
Bio-Rad
F. Hoffmann-La Roche AG
Fluidigm
Illumina
Qiagen
RainDance Technologies
Thermo Fisher Scientific

Chapter 9: Challenges and Strategic Recommendations
Challenges
Strategic Recommendations

For more information about this report visit http://www.researchandmarkets.com/research/f7pwmf/cellfree_dna

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Computing and Technology, Healthcare Services